Search results for "antihypertensive"

showing 10 items of 203 documents

The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2)

2012

Observational studies have shown that 24-h and morning ambulatory blood pressure (BP) control is low. This large-scale, practice-based study evaluated the effects of telmisartan 40 or 80 mg alone or in combination with hydrochlorothiazide (HCTZ) 12.5 mg on these BP parameters over 8 weeks; treatment was adjusted if clinic BP remained ≥140/90 mm Hg. A total of 863 patients were evaluated (baseline mean clinic BP, morning and 24-h ambulatory BP: 155±15/93±10 mm Hg, 137±15/83±11 mm Hg, 133±14/79±10 mm Hg, respectively; 68% were previously treated at baseline). Telmisartan with/without HCTZ significantly reduced the mean morning ambulatory BP (-8.2/-4.9 mm Hg), daytime ambulatory BP (-8.0/-4.7 …

Malemedicine.medical_specialtyAmbulatory blood pressureAdolescentPhysiologyAngiotensin-Converting Enzyme InhibitorsBlood PressurePharmacologyBenzoatesYoung AdultHydrochlorothiazideReference ValuesAmbulatory CareInternal MedicinemedicineHumansTelmisartanambulatory blood pressure monitoring hidro hydrochlorothiazide morning blood pressure control telmisartanAntihypertensive AgentsAgedMorningAged 80 and overbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring AmbulatoryMiddle AgedCircadian RhythmDrug CombinationsHydrochlorothiazideTreatment OutcomeHypertensionAmbulatoryEmergency medicineBenzimidazolesDrug Therapy CombinationFemaleTelmisartanCardiology and Cardiovascular Medicinebusinessmedicine.drugHypertension Research
researchProduct

Twenty-four-hour ambulatory heart rate and organ damage in primary hypertension.

2010

The relationship between basal heart rate (HR) and the occurrence of myocardial ischemia, sudden death, cardiovascular mortality have been described. Therefore, further studies are warranted to evaluate the behaviour of heart rate in different scenarios. We sought to determine whether ambulatory heart rate is associated with the presence of target organ damage (TOD) in hypertensive patients.Crossectional study of essential hypertensive patients in whom a twenty-four hour ambulatory blood pressure monitoring (ABPM) was performed. The relationship between TOD and 24 hour ambulatory heart rate (HR) was analyzed.Five hundred and sixty-six patients with arterial hypertension were included (55.8%…

Malemedicine.medical_specialtyAmbulatory blood pressureCross-sectional studyMyocardial IschemiaBlood PressureSudden deathBrain IschemiaHeart RateRisk FactorsDiabetes mellitusInternal medicineSurveys and QuestionnairesHeart rateInternal MedicinemedicineHumansAntihypertensive Agentsbusiness.industryGeneral MedicineBlood Pressure Monitoring AmbulatoryMiddle Agedmedicine.diseaseBlood pressureCross-Sectional StudiesCardiovascular DiseasesAmbulatoryHypertensionCardiologyFemaleCardiology and Cardiovascular MedicinebusinessDyslipidemiaBlood pressure
researchProduct

Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE s…

2010

AimsLimited information is available on office and ambulatory blood pressure (BP) control as well as on cardiovascular (CV) risk profile in treated hypertensive patients living in central and eastern European countries.Methods and resultsIn 2008, a survey on 7860 treated hypertensive patients followed by non-specialist or specialist physicians was carried out in nine central and eastern European countries (Albania, Belarus, Bosnia, Czech Republic, Latvia, Romania, Serbia, Slovakia, and Ukraine). Cardiovascular risk assessment was based on personal history, clinic BP values, as well as target organ damage evaluation. Patients had a mean (±SD) age of 60.1 ± 11 years, and the majority of them …

Malemedicine.medical_specialtyAmbulatory blood pressureCross-sectional studyRisk AssessmentRisk FactorsInternal medicinemedicineAlbuminuriaHumansBlood pressure cardiovascular risk risk factors hypertensionEurope EasternStrokeAntihypertensive AgentsAgedbusiness.industryMiddle Agedmedicine.diseaseSurgeryEastern europeanEuropeBlood pressureCross-Sectional StudiesCardiovascular DiseasesAmbulatoryHypertensionElectrocardiography AmbulatoryMicroalbuminuriaDrug Therapy CombinationFemaleCardiology and Cardiovascular MedicineRisk assessmentbusinessEuropean heart journal
researchProduct

Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring.

2007

To perform a systematic review of the antihypertensive activity of the angiotensin II AT1 receptor antagonists (ARB).Studies in which blood pressure (BP) was measured using ambulatory BP monitoring for at least 24 h were collected from MEDLINE. Data for each treatment group, ARB, placebo or the drug used for its comparison were obtained from the selected studies. Only studies with a minimum of quality criteria were selected. The final study group contained 36 publications, with a total of 47 patient cohorts receiving ARB in monotherapy, 10 with placebo, 10 with amlodipine, and five with enalapril. The reduction in clinical and ambulatory BP during 24 h, day, night and the last 4-h period fo…

Malemedicine.medical_specialtyAmbulatory blood pressurePhysiologyMEDLINEPharmacologyurologic and male genital diseasesEnalaprilInternal medicineInternal MedicinemedicineHumanscardiovascular diseasesAntihypertensive AgentsAngiotensin II receptor type 1Dose-Response Relationship Drugbusiness.industryEprosartanBlood Pressure Monitoring AmbulatoryAngiotensin IIfemale genital diseases and pregnancy complicationsEndocrinologyLosartanValsartanACE inhibitorHypertensionFemaleAmlodipineTelmisartanCardiology and Cardiovascular MedicinebusinessAngiotensin II Type 1 Receptor Blockershormones hormone substitutes and hormone antagonistsmedicine.drugJournal of hypertension
researchProduct

Antihypertensive Mechanism of Lactoferrin-Derived Peptides: Angiotensin Receptor Blocking Effect

2013

Texto del artículo, no incluye figuras ni tablas.

Malemedicine.medical_specialtyAngiotensin receptorPeptideLactoferrin-derived peptidesReceptor Angiotensin Type 1Angiotensin Receptor AntagonistsInternal medicineRenin–angiotensin systemmedicineAnimalsHumansAngiotensin receptor blockerRenin−angiotensin systemReceptorAntihypertensive Agentschemistry.chemical_classificationAngiotensin II receptor type 1Antihypertensive mechanismbiologyLactoferrinAngiotensin IIBovine lactoferrin hydrolysateGeneral ChemistryAngiotensin IIMolecular WeightLactoferrinEndocrinologychemistryVasoconstrictionAngiotensin-converting enzyme inhibitorHypertensionbiology.proteinRabbitsPeptidesGeneral Agricultural and Biological SciencesEx vivo
researchProduct

Drug induced variations of the renin-angiotensin-aldosterone system in rats. II. Antihypertensives

1977

Summary Groups of male rats were treated with antihypertensive drugs (alpha-methyl-dopa, clonidine, propranolol, reserpine, diazoxide) which were administered under conditions causing the onset of high plasma renin activity (PRA) and high plasma and urine aldosterone levels, i.e. together with distilled water load (5% of body weight). Alpha-methyl-dopa and propranolol, which fail to significantly alter PRA and plasma aldosterone levels when administered without distilled water load, cause a marked decrease of plasma and urine aldosterone levels and of PRA when administered together with distilled water load, while diazoxide, and reserpine cause a marked increase of these values. Clonidine c…

Malemedicine.medical_specialtyBlood PressurePropranololPharmacologyPlasma renin activityInternal medicineReninRenin–angiotensin systemmedicineDiazoxideAnimalsAldosteroneAntihypertensive AgentsPharmacologyKidneyChemistryAngiotensin IIReserpineDiuresisRatsClonidinemedicine.anatomical_structureEndocrinologyVascular resistancemedicine.drugPharmacological Research Communications
researchProduct

β-Blockers in Patients With Intermittent Claudication and Arterial Hypertension

2011

The use of β-receptor blockers in peripheral arterial disease is controversial for their impact on vasomotor tone. The β-blocker nebivolol possesses vasodilating, endothelium-dependent, NO-releasing properties that might be beneficial in peripheral arterial disease. The aim of the study was to evaluate the effects and tolerability of nebivolol in comparison with metoprolol in these patients. A total of 128 patients with intermittent claudication and essential hypertension were included and double-blind randomized to receive 5 mg of nebivolol (N=65) or 95 mg of metoprolol (N=63) once daily. End points were changes in ankle-brachial index, initial and absolute claudication distance, endothel…

Malemedicine.medical_specialtyBrachial ArteryAdrenergic beta-AntagonistsArterial Occlusive DiseasesBlood PressureEssential hypertensionNebivololDouble-Blind MethodSurveys and QuestionnairesInternal medicinemedicine.arteryInternal MedicinemedicineHumansAnkle Brachial IndexBenzopyransBrachial arteryAntihypertensive AgentsMetoprololbusiness.industryIntermittent Claudicationmedicine.diseaseNebivololIntermittent claudicationTreatment OutcomeBlood pressureTolerabilityEthanolaminesAnesthesiaHypertensionQuality of LifeCardiologyFemalemedicine.symptomClaudicationbusinessMetoprololmedicine.drugHypertension
researchProduct

Novel antihypertensive hexa- and heptapeptides with ACE-inhibiting properties: From the in vitro ACE assay to the spontaneously hypertensive rat

2011

Bioactive ACE inhibiting peptides are gaining interest in hypertension treatment. We have designed and screened six synthetic heptapeptides (PACEI48 to PACEI53) based on two hexapeptide leads (PACEI32 and PACEI34) to improve ACE inhibitory properties and assess their antihypertensive effects. ACE activity was assayed in vitro and ex vivo. Selected peptides were administered to spontaneously hypertensive rats (SHRs) and normotensive Wistar-Kyoto (WKY) rats. In vitro cytotoxicity was assessed with the MTT reduction test. The six heptapeptides at low micromolar concentration produced different degrees of in vitro inhibition of ACE activity using the synthetic substrate HHL or the natural subst…

Malemedicine.medical_specialtyCell SurvivalPhysiologyAdministration OralAngiotensin-Converting Enzyme InhibitorsBlood PressurePeptidyl-Dipeptidase APharmacologyRats Inbred WKYBiochemistryTissue Culture TechniquesMiceCellular and Molecular NeuroscienceEndocrinologySpontaneously hypertensive ratOral administrationRats Inbred SHRInternal medicineRenin–angiotensin systemmedicineAnimalsHumansInfusions IntravenousAntihypertensive AgentsbiologyChemistryAngiotensin-converting enzyme3T3 CellsHep G2 CellsIn vitroRatsCarotid ArteriesEndocrinologyVasoconstrictionHypertensionACE inhibitorbiology.proteinRabbitsAngiotensin Imedicine.symptomOligopeptidesVasoconstrictionEx vivomedicine.drug
researchProduct

Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement

2020

Typical posterior reversible encephalopathy syndrome (PRES) is a clinical-neuroradiological entity characterised by bilateral white matter oedema, which is usually symmetrical and totally reversible in 2–3 weeks. A 46-year-old man presented with a persistent headache and visual blurring in the right eye. On admission, the clinical examination revealed minimal unsteadiness of gait and elevated blood pressure. A brain MRI showed a hyperintense signal on T2-weighted sequences in the whole brainstem, extended to the spinal cord (C2–C6), the left insula and the right cerebellum. When his blood pressure was controlled, his symptoms gradually improved. The follow-up MRI scan at 3 weeks revealed a …

Malemedicine.medical_specialtyCerebellumNeurologyNifedipinePhysical examination030218 nuclear medicine & medical imagingWhite matterDiagnosis Differential03 medical and health sciences0302 clinical medicineRamiprilmedicineHumansAntihypertensive AgentsUnusual Presentation of More Common Disease/Injuryneuroimagingmedicine.diagnostic_testbusiness.industryneurologyBrain stem/cerebellumDoxazosinPosterior reversible encephalopathy syndromeGeneral MedicineMiddle AgedSpinal cordmedicine.diseaseCalcium Channel BlockersMagnetic Resonance ImagingWhite Matterradiologymedicine.anatomical_structureSettore MED/26 - NeurologiaRadiologyBrainstemPosterior Leukoencephalopathy SyndromeDifferential diagnosisbusinessneuro-oncology030217 neurology & neurosurgeryBrain Stem
researchProduct

Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study.

2018

Background: The aim of this study was to assess the expression of cytokines/chemokines in tears from patients with non-advanced primary open-angle glaucoma and patients with non-severe dry eye disease versus healthy controls. Methods: This prospective, observational cohort study enrolled patients with confirmed or suspected non-advanced primary open-angle glaucoma who received any prostaglandin analogue monotherapy for longer than 6 months, patients with non-severe dry eye disease, and healthy controls. Expression of interleukin-1β, interleukin-2, interleukin-4, interleukin-5, interleukin-6, interleukin-8, interleukin-10, and interleukin-12; tumor necrosis factor α; vascular endothelial gro…

Malemedicine.medical_specialtyChemokineGlaucomaInflammationDiseaseCohort Studies03 medical and health sciences0302 clinical medicineOphthalmologymedicineHumansProspective StudiesEye ProteinsAntihypertensive AgentsIntraocular PressureAgedbiologybusiness.industryPreservatives PharmaceuticalCytokine expressionGeneral MedicineMiddle Agedmedicine.diseaseOphthalmologyTears030221 ophthalmology & optometrybiology.proteinTearsCytokinesDry Eye SyndromesFemalemedicine.symptomOphthalmic Solutionsbusiness030217 neurology & neurosurgeryGlaucoma Open-AngleCohort studyEuropean journal of ophthalmology
researchProduct